Citadel Advisors - DECIBEL THERAPEUTICS INC ownership

DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 44 filers reported holding DECIBEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of DECIBEL THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,823,477
-42.8%
1,865,111
-3.5%
0.00%0.0%
Q3 2022$6,686,000
-21.5%
1,932,286
-4.4%
0.00%
-50.0%
Q2 2022$8,513,000
+52.5%
2,021,908
+10.1%
0.00%
+100.0%
Q1 2022$5,581,000
-34.3%
1,835,891
+0.5%
0.00%
-50.0%
Q4 2021$8,495,000
-38.0%
1,826,961
+2.8%
0.00%
-33.3%
Q3 2021$13,706,000
-8.2%
1,777,659
+0.2%
0.00%0.0%
Q2 2021$14,935,000
-26.1%
1,773,831
-0.3%
0.00%
-40.0%
Q1 2021$20,203,0001,778,3960.01%
Other shareholders
DECIBEL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ATLAS CAPITAL ADVISORS LLC 40,000$36,4000.01%
View complete list of DECIBEL THERAPEUTICS INC shareholders